Cigna Stock Analysis: Challenges and Recovery Potential

Cigna Corporation (NYSE:CI) recently hit a 52-week low at $288.86, marking a challenging phase for the healthcare giant. Despite this, Cigna maintains resilience, supported by a 43-year streak of dividend payments with a 13.8% growth last year. The company's management demonstrates …

CouponFollow Extension

8%
OFF

Cigna Stock Analysis: Challenges And Recovery Potential

2 weeks from now

investingsnacks.com

47%
OFF

Breaking Down Cigna: 5 Analysts Share Their Views

2 weeks from now

Jan 31, 2025 · Return on Assets (ROA): Cigna's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.47%, the company may …

benzinga.com

$63.69
OFF

Decoding The Cigna Group (CI): A Strategic SWOT Insight - Yahoo …

2 weeks from now

Nov 1, 2024 · The Cigna Group, a leader in pharmacy benefit management and health insurance services, reported a total revenue of $63.694 billion for the third quarter of 2024, a significant …

yahoo.com

$288.86
OFF

Cigna Stock Touches 52-week Low At $288.86 Amid Market Shifts

2 weeks from now

Dec 12, 2024 · In a market environment fraught with challenges, Cigna Corporation (NYSE: CI)'s stock has touched a 52-week low, dipping to $288.86.This price point marks a notable trough …

investing.com

9%
OFF

Cigna Stock Outlook: Rising Healthcare Costs And Growth Potential

2 weeks from now

5 days ago · Cigna's medical care ratio (MCR) rose to 87.9%, up from 82.2% in the year-ago period, meaning they are paying out 87.9% of the health insurance premiums they collect for …

marketbeat.com

89%
OFF

Cigna's Market Loss: Impact On Investors - CI Stock

2 weeks from now

Dec 12, 2024 · The Cigna Group (NYSE:CI) experienced a US$6.5 billion market value loss last week, impacting its institutional investors, who collectively own 89% of the company. Despite …

investingsnacks.com

7%
OFF

Cigna Stock Plunges 18.7% In 3 Months: Should You Buy, Hold Or …

2 weeks from now

Jan 7, 2025 · The stock is currently trading below its 50-day and 200-day moving average, signaling potential downward momentum. CI's 3-Month Price Performance Comparison Image …

zacks.com

$263.67
OFF

Cigna Stock Dips Despite Positive Analyst Ratings - CI Stock

2 weeks from now

Dec 18, 2024 · The Cigna Group (NYSE:CI) shares dropped sharply, opening at $263.67 after previously closing at $273.26. Several analysts maintain a positive outlook on the stock, with …

investingsnacks.com

FAQs about Cigna Stock Analysis: Challenges and Recovery Potential Coupon?

How will Cigna's merger impact its stock value?

However, it also presents risks related to shareholder approval, deal accretion, and debt levels. The potential for a period of uncertainty during merger discussions, which could last up to two years, has led some analysts to caution about the near-term impact on Cigna's stock value. Looking ahead, Cigna faces both tailwinds and headwinds. ...

Is Cigna (CI) a good stock to buy?

Cigna Corporation (NYSE:CI), a leading global health services organization, has been navigating a complex landscape of challenges and opportunities in recent months. With a market capitalization of $81.35 billion and according to InvestingPro analysis, Cigna is currently trading below its Fair Value, suggesting potential upside opportunity. ...

Should you buy Cigna (CI – Research Report)?

In a report released yesterday, Lance Wilkes from Bernstein maintained a Buy rating on Cigna (CI – Research Report), with a price target of $411.00. Lance Wilkes has given his Buy rating due to a combination of factors pertaining to Cigna’s solid position in the specialty drug market, which is rapidly expanding. ...

How will Cigna's recent earnings miss affect its profitability?

The recent earnings miss due to high-cost claims in the Stop-Loss business raises concerns about Cigna's ability to manage risk effectively. If this trend continues or spreads to other segments of the business, it could significantly impact the company's profitability. ...

Is Cigna a good investment?

Despite regulatory challenges, Cigna’s ability to demonstrate their critical role in patient care to regulators signifies resilience and potential for value creation, contributing to the Outperform rating and an ambitious target price of $411. ...

How will Cigna's strategic decisions affect shareholder value?

Analysts view Cigna's strategic decisions, including capital deployment towards share repurchases rather than acquisitions, as positive moves that could enhance shareholder value. Technology investments, such as the integration of MDLIVE, demonstrate Cigna's commitment to innovation and long-term growth. ...